FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076177319> ?p ?o ?g. }

• W2076177319 endingPage "1904" @default.
• W2076177319 startingPage "1898" @default.
• W2076177319 abstract "The aim of this study was to assess the activity and toxicity of a platinum-based treatment on a group of patients with unknown primary tumours (UPTs). Patients with a diagnosis of UPT underwent a standard diagnostic procedure. Treatment was started within 2 weeks from diagnosis and consisted of carboplatin 400 mg m(-2) day 1, doxorubicin 50 mg m(-2) day 1, etoposide 100 mg m(-2) days 1-3, every 21 days. Response was evaluated after three courses and treatment continued in case of objective response (OR) or symptom control. A total of 102 patients were eligible. The median age was 59 years, sex male/female 54/48, histology was mainly adenocarcinoma or poorly differentiated carcinoma. Nodes, bone, liver and lung were the most frequently involved sites. In all, 79 patients received at least three courses of treatment; 26 patients received six courses or more. Six complete responses and 21 partial responses were observed, for a total of 27 of 102 ORs or 26.5% (95% confidence interval 18.2-36.1%). The median survival was 9 months and median progression-free survival was 4 months. Toxicity was moderate to severe, with 57.8% of patients experiencing grade III-IV haematological toxicity, mainly leucopenia. The regimen employed has shown activity in tumours of unknown primary site, but was associated with significant toxicity. Such toxicity may be considered unjustified, given the large proportion of patients with tumours not likely to respond. Efforts should therefore be addressed to identify predictors of response to chemotherapy, thus limiting aggressive treatment to those patients who could benefit from it." @default.
• W2076177319 created "2016-06-24" @default.
• W2076177319 creator A5001495249 @default.
• W2076177319 creator A5007854370 @default.
• W2076177319 creator A5014868069 @default.
• W2076177319 creator A5018226027 @default.
• W2076177319 creator A5033308266 @default.
• W2076177319 creator A5042730055 @default.
• W2076177319 creator A5046557950 @default.
• W2076177319 creator A5048376385 @default.
• W2076177319 creator A5055056275 @default.
• W2076177319 creator A5055185357 @default.
• W2076177319 creator A5058495826 @default.
• W2076177319 creator A5063057695 @default.
• W2076177319 creator A5063792008 @default.
• W2076177319 creator A5082021602 @default.
• W2076177319 date "2004-04-13" @default.
• W2076177319 modified "2023-10-18" @default.
• W2076177319 title "Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site" @default.
• W2076177319 cites W103698556 @default.
• W2076177319 cites W10844698 @default.
• W2076177319 cites W1550111394 @default.
• W2076177319 cites W1772474515 @default.
• W2076177319 cites W1890674505 @default.
• W2076177319 cites W1894205425 @default.
• W2076177319 cites W1908498093 @default.
• W2076177319 cites W1913120928 @default.
• W2076177319 cites W1957029226 @default.
• W2076177319 cites W1964998139 @default.
• W2076177319 cites W1972615495 @default.
• W2076177319 cites W1983333559 @default.
• W2076177319 cites W2000456654 @default.
• W2076177319 cites W2005905993 @default.
• W2076177319 cites W2009459729 @default.
• W2076177319 cites W2015001868 @default.
• W2076177319 cites W2021047864 @default.
• W2076177319 cites W2035106376 @default.
• W2076177319 cites W2038625776 @default.
• W2076177319 cites W2045636613 @default.
• W2076177319 cites W2066106964 @default.
• W2076177319 cites W2079809799 @default.
• W2076177319 cites W2090246193 @default.
• W2076177319 cites W2093553701 @default.
• W2076177319 cites W2097277875 @default.
• W2076177319 cites W2098143278 @default.
• W2076177319 cites W2099615725 @default.
• W2076177319 cites W2112126084 @default.
• W2076177319 cites W2116996913 @default.
• W2076177319 cites W2118142440 @default.
• W2076177319 cites W2157532562 @default.
• W2076177319 cites W2161394160 @default.
• W2076177319 cites W2167805334 @default.
• W2076177319 cites W2170381595 @default.
• W2076177319 cites W2275567662 @default.
• W2076177319 cites W2285683947 @default.
• W2076177319 cites W2304712933 @default.
• W2076177319 cites W2319509503 @default.
• W2076177319 cites W2322693032 @default.
• W2076177319 cites W23308814 @default.
• W2076177319 cites W2333179120 @default.
• W2076177319 cites W2417173780 @default.
• W2076177319 cites W2417984197 @default.
• W2076177319 cites W288788516 @default.
• W2076177319 cites W4285719527 @default.
• W2076177319 doi "https://doi.org/10.1038/sj.bjc.6601785" @default.
• W2076177319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2409455" @default.
• W2076177319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15138469" @default.
• W2076177319 hasPublicationYear "2004" @default.
• W2076177319 type Work @default.
• W2076177319 sameAs 2076177319 @default.
• W2076177319 citedByCount "20" @default.
• W2076177319 countsByYear W20761773192012 @default.
• W2076177319 countsByYear W20761773192013 @default.
• W2076177319 countsByYear W20761773192017 @default.
• W2076177319 countsByYear W20761773192018 @default.
• W2076177319 countsByYear W20761773192022 @default.
• W2076177319 countsByYear W20761773192023 @default.
• W2076177319 crossrefType "journal-article" @default.
• W2076177319 hasAuthorship W2076177319A5001495249 @default.
• W2076177319 hasAuthorship W2076177319A5007854370 @default.
• W2076177319 hasAuthorship W2076177319A5014868069 @default.
• W2076177319 hasAuthorship W2076177319A5018226027 @default.
• W2076177319 hasAuthorship W2076177319A5033308266 @default.
• W2076177319 hasAuthorship W2076177319A5042730055 @default.
• W2076177319 hasAuthorship W2076177319A5046557950 @default.
• W2076177319 hasAuthorship W2076177319A5048376385 @default.
• W2076177319 hasAuthorship W2076177319A5055056275 @default.
• W2076177319 hasAuthorship W2076177319A5055185357 @default.
• W2076177319 hasAuthorship W2076177319A5058495826 @default.
• W2076177319 hasAuthorship W2076177319A5063057695 @default.
• W2076177319 hasAuthorship W2076177319A5063792008 @default.
• W2076177319 hasAuthorship W2076177319A5082021602 @default.
• W2076177319 hasBestOaLocation W20761773191 @default.
• W2076177319 hasConcept C126322002 @default.
• W2076177319 hasConcept C141071460 @default.
• W2076177319 hasConcept C2776694085 @default.
• W2076177319 hasConcept C2778119113 @default.
• W2076177319 hasConcept C2778239845 @default.

• next